ABCG1 maintains high-grade glioma survival  in vitro  and  in vivo

Yi-Hsien Chen; Patrick J. Cimino; Jingqin Luo; Sonika Dahiya; David H. Gutmann

doi:10.18632/oncotarget.8030

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

ABCG1 maintains high-grade glioma survival in vitro and in vivo

Yi-Hsien Chen, Patrick J. Cimino, Jingqin Luo, Sonika Dahiya and David H. Gutmann _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:23416-23424. https://doi.org/10.18632/oncotarget.8030

Metrics: PDF 1750 views | HTML 2222 views | ?

Abstract

Yi-Hsien Chen1, Patrick J. Cimino2, Jingqin Luo3, Sonika Dahiya2, David H. Gutmann1

1Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA

2Department of Pathology, Washington University School of Medicine, St. Louis, MO, USA

3Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA

Correspondence to:

David H. Gutmann, e-mail: [email protected]

Keywords: glioblastoma, ER stress, brain tumor, glioma stem cell, apoptosis

Received: September 29, 2015 Accepted: February 25, 2016 Published: March 10, 2016

ABSTRACT

The overall survival for adults with malignant glioma (glioblastoma) remains poor despite advances in radiation and chemotherapy. One of the mechanisms by which cancer cells develop relative resistance to treatment is through de-regulation of endoplasmic reticulum (ER) homeostasis. We have recently shown that ABCG1, an ATP-binding cassette transporter, maintains ER homeostasis and suppresses ER stress-induced apoptosis in low-grade glioma. Herein, we demonstrate that ABCG1 expression is increased in human adult glioblastoma, where it correlates with poor survival in individuals with the mesenchymal subtype. Leveraging a mouse model of mesenchymal glioblastoma (NPcis), shRNA-mediated Abcg1 knockdown (KD) increased CHOP ER stress protein expression and resulted in greater NPcis glioma cell death in vitro. Moreover, Abcg1 KD reduced NPcis glioma growth and increased mouse survival in vivo. Collectively, these results demonstrate that ABCG1 is critical for malignant glioma cell survival, and might serve as a future therapeutic target for these deadly brain cancers.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8030

Publication Alerts

Research Papers:

ABCG1 maintains high-grade glioma survival in vitro and in vivo

Abstract